BGB-102
BGB-102 (JNJ-26483327) is a kinase inhibitor targeting FLT3 and YES1 and an antagonist targeting EGFR and VEGFR3, which may be useful in the study of macular degeneration and diseases associated with genetic disorders and malformations.
Product Specifications
CAS Number
807640-87-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
457.36
Molecular Formula
C22H25BrN4O2
Notes
Research use only, not for human use.
Receptor
FLT | VEGFR | EGFR | Src
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog